Bessemer Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3K Hold
206
﹤0.01% 2159
2025
Q1
$4K Buy
206
+41
+25% +$796 ﹤0.01% 2117
2024
Q4
$3K Hold
165
﹤0.01% 2164
2024
Q3
$2K Sell
165
-169
-51% -$2.05K ﹤0.01% 2283
2024
Q2
$3K Buy
+334
New +$3K ﹤0.01% 1902
2022
Q2
Sell
-221
Closed -$6K 2045
2022
Q1
$6K Hold
221
﹤0.01% 1487
2021
Q4
$7K Hold
221
﹤0.01% 1511
2021
Q3
$5K Hold
221
﹤0.01% 1522
2021
Q2
$3K Hold
221
﹤0.01% 1496
2021
Q1
$6K Buy
+221
New +$6K ﹤0.01% 1381
2020
Q3
Sell
-99,800
Closed -$2.04M 1664
2020
Q2
$2.04M Buy
+99,800
New +$2.04M 0.01% 473
2019
Q4
Sell
-66
Closed -$1K 1772
2019
Q3
$1K Buy
+66
New +$1K ﹤0.01% 1686